||||||||||MUC-1 CD40L dendritic cell vaccine / MicroVAX Trial primary completion date, IO biomarker, Viral vector: Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers (clinicaltrials.gov) - Nov 19, 2015 P1, N=24, Recruiting, Sponsor: Singapore Clinical Research Institute Trial primary completion date: Nov 2016 --> Mar 2017 Trial primary completion date: Oct 2015 --> Nov 2016
||||||||||MUC-1 CD40L dendritic cell vaccine / MicroVAX Enrollment open, Trial initiation date, IO biomarker, Viral vector: Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers (clinicaltrials.gov) - Jan 22, 2015 P1, N=24, Recruiting, Sponsor: Singapore Clinical Research Institute Trial primary completion date: Oct 2015 --> Nov 2016 Not yet recruiting --> Recruiting | Initiation date: Jun 2014 --> Sep 2014